RVMD earnings date and last-quarter result: last quarter miss, P/E -25.74. Updated 2026-07-23.
Revolution Medicines (RVMD) Research Hub
Revolution Medicines (RVMD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 183.9 USD (-1.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -25.74, market cap 38.93B. This hub links to the full technical, earnings and options research available for RVMD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 183.9 USD (-1.65%) |
| 52-week range | 152.89 USD – 221.5 USD |
| Trend regime | Range |
| 14-day RSI | 39.6 (Bearish) |
| Trailing P/E | -25.74 |
| Market cap | 38.93B |
| Dividend yield | 0.00% |
Available research for RVMD
Covered Call on RVMD: how it works, illustrative setup around the real 183.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RVMD: how it works, illustrative setup around the real 183.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RVMD: how it works, illustrative setup around the real 183.9 USD price, max profit/loss, breakeven and when to use it. Educational.
RVMD technical analysis: range, last 183.9 USD, RSI 39.6, 52w range 152.89 USD–221.5 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RVMD in?
Revolution Medicines (RVMD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RVMD in an uptrend or downtrend?
As of 2026-10-26, RVMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RVMD's trailing P/E ratio?
RVMD's trailing P/E is -25.74, with a market cap of 38.93B. See the earnings research page for full valuation detail.